Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (311-320 of 753) with videos related to

Pageof 76
Sort By:
Anti-Cancer Drugs|July 5, 2012
Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?Angela Esposito, Elisabetta Munzone, Vincenzo Bagnardi, et al.
Journal of Pain and Symptom Management|October 6, 2000
Palliative care consultations: how do they impact the care of hospitalized patients?P L Manfredi, R S Morrison, J Morris, et al.
Human Pathology|December 1, 1985
Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasisB W Davis, R Gelber, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observationM Waeber, M Castiglione-Gertsch, D Dietrich, et al.
Cancer Treatment Reviews|March 23, 2010
Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomyAlessandra Balduzzi, Maria Cristina Leonardi, Anna Cardillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2018
Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the MicrobiomeLaura Pala, Luigi Nezi, Tommaso De Pas, et al.
Seminars in Oncology|November 28, 1997
Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancerC Sessa, O Pagani, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Paclitaxel induces significant changes in epidoxorubicin distribution in miceT Colombo, O Gonzalez Paz, M Zucchetti, et al.
Journal of Palliative Medicine|September 16, 2020
Creating a Colocation Unit for End-of-Life Care during a PandemicOlusegun Apoeso, Caitlyn Kuwata, Suzanne L Goldhirsch, et al.
European Urology|September 19, 2018
Reply to Jeffrey Graham, Omar Abdel-Rahman, Toni K. Choueiri, and Daniel Y.C. Heng's Letter to the Editor re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737-46: Outcomes of Metastatic Renal Cell Carcinoma by Gender: Contrasting Results from the International mRCC Database ConsortiumFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Pageof 76

Showing results (311-320 of 753) with videos related to

Sort By:
Pageof 76
Anti-Cancer Drugs|July 5, 2012
Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?Angela Esposito, Elisabetta Munzone, Vincenzo Bagnardi, et al.
Journal of Pain and Symptom Management|October 6, 2000
Palliative care consultations: how do they impact the care of hospitalized patients?P L Manfredi, R S Morrison, J Morris, et al.
Human Pathology|December 1, 1985
Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasisB W Davis, R Gelber, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observationM Waeber, M Castiglione-Gertsch, D Dietrich, et al.
Cancer Treatment Reviews|March 23, 2010
Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomyAlessandra Balduzzi, Maria Cristina Leonardi, Anna Cardillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2018
Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the MicrobiomeLaura Pala, Luigi Nezi, Tommaso De Pas, et al.
Seminars in Oncology|November 28, 1997
Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancerC Sessa, O Pagani, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Paclitaxel induces significant changes in epidoxorubicin distribution in miceT Colombo, O Gonzalez Paz, M Zucchetti, et al.
Journal of Palliative Medicine|September 16, 2020
Creating a Colocation Unit for End-of-Life Care during a PandemicOlusegun Apoeso, Caitlyn Kuwata, Suzanne L Goldhirsch, et al.
European Urology|September 19, 2018
Reply to Jeffrey Graham, Omar Abdel-Rahman, Toni K. Choueiri, and Daniel Y.C. Heng's Letter to the Editor re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737-46: Outcomes of Metastatic Renal Cell Carcinoma by Gender: Contrasting Results from the International mRCC Database ConsortiumFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Pageof 76